Cell Mutants Defective in Cholesterol Ester Formation

胆固醇酯形成有缺陷的细胞突变体

基本信息

  • 批准号:
    8139180
  • 负责人:
  • 金额:
    $ 45.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1989
  • 资助国家:
    美国
  • 起止时间:
    1989-07-01 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of this research program is to understand the molecular mechanisms involved in the regulation of intracellular cholesterol metabolism. Based on results presented in PRELIMINARY STUDIES, in the forthcoming granting period the focus will be on studying the mechanisms of cellular cholesterol trafficking and storage processes in mammalian cells. Two Specific Aims are proposed: Specific Aim 1: To test the hypothesis that the trans-Golgi network (TGN) serves as a key organelle for transporting low-density lipoprotein (LDL)-derived cholesterol from the endosomes to the plasma membrane/endoplasmic reticulum (ER). SubAim 1.1: To test the possibility that membranes containing the Syntaxin 6/Syntaxin 16/Vti1a complex play a key role in LDL-CHOL trafficking. SubAim 1.2: To test the possibility that the v-SNAREs Vamp4/Vamp3 may contribute to LDL- CHOL transport between the NPC1 compartment and the Syntaxin 6-rich compartment. SubAim 1.3: To biochemically characterize various membrane compartments associated with 3H-CHOL derived from LDL. Specific Aim 2: To examine the functional and biochemical characteristics of caveolae in the ER. SubAim 2.1: To examine the functional characteristics of the ER caveolae in intact cells and in vitro. SubAim 2.2: To examine the biochemical characteristics of the ER caveolae in intact cells and in vitro. LDL is the major cholesterol carrier in the blood. High LDL is a risk factor for atherosclerosis, which is a major cause of heart disease. The outcome of research described in the current application will bring new knowledge about the intracellular transport and storage processes of LDL-derived cholesterol, and may help develop new approaches for reducing the amount of LDL-derived cholesterol stored in tissues. PUBLIC HEALTH RELEVANCE: Low-density lipoprotein (LDL) is the major cholesterol carrier in the blood. High LDL is a risk factor for atherosclerosis, which is a major cause of heart disease. The outcome of research described in the current application will bring new knowledge about the transport and storage process of LDL-derived cholesterol, and may help develop new approaches for reducing the amount of LDL-derived cholesterol stored in tissues.
描述(由申请人提供):该研究计划的长期目标是了解调节细胞内胆固醇代谢的分子机制。基于初步研究中提出的结果,在即将到来的授予期内,重点将放在研究哺乳动物细胞中细胞胆固醇运输和储存过程的机制上。提出了两个具体目的:具体目的1:测试跨加利基网络(TGN)是将低密度脂蛋白(LDL)衍生的胆固醇从内体转移到质膜/内胞质网状(ER)的关键细胞器。 Subaim 1.1:测试含有语法6/语法6/VTI1A复合物的膜在LDL-Chol运输中起关键作用的可能性。 Subaim 1.2:为了测试V-SNARES VAMP4/VAMP3可能有可能导致NPC1隔室和富含语法6的富含语法的室之间的LDL-CHOL转运的可能性。 Subaim 1.3:生化表征与来自LDL的3H-Chol相关的各种膜室。特定目的2:检查Caveolae在ER中的功能和生化特征。 Subaim 2.1:检查完整细胞和体外中ER小窝的功能特征。 Subaim 2.2:检查完整细胞和体外中ER小窝的生化特征。 LDL是血液中的主要胆固醇载体。高LDL是动脉粥样硬化的危险因素,这是心脏病的主要原因。当前应用中描述的研究结果将带来有关LDL衍生的胆固醇细胞内运输和储存过程的新知识,并可能有助于开发新方法,以减少储存在组织中的LDL衍生胆固醇的量。公共卫生相关性:低密度脂蛋白(LDL)是血液中的主要胆固醇载体。高LDL是动脉粥样硬化的危险因素,这是心脏病的主要原因。当前应用中描述的研究结果将带来有关LDL衍生胆固醇的运输和存储过程的新知识,并可能有助于开发新的方法来减少LDL衍生的胆固醇量的量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ta Yuan CHANG其他文献

Ta Yuan CHANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ta Yuan CHANG', 18)}}的其他基金

Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage
通过阻断胆固醇储存来缓解 ADRD 中的溶酶体脂质缺陷
  • 批准号:
    9977871
  • 财政年份:
    2018
  • 资助金额:
    $ 45.13万
  • 项目类别:
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage
通过阻断胆固醇储存来缓解 ADRD 中的溶酶体脂质缺陷
  • 批准号:
    9789810
  • 财政年份:
    2018
  • 资助金额:
    $ 45.13万
  • 项目类别:
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage
通过阻断胆固醇储存来缓解 ADRD 中的溶酶体脂质缺陷
  • 批准号:
    10202476
  • 财政年份:
    2018
  • 资助金额:
    $ 45.13万
  • 项目类别:
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage
通过阻断胆固醇储存来缓解 ADRD 中的溶酶体脂质缺陷
  • 批准号:
    10187943
  • 财政年份:
    2018
  • 资助金额:
    $ 45.13万
  • 项目类别:
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage
通过阻断胆固醇储存来缓解 ADRD 中的溶酶体脂质缺陷
  • 批准号:
    9933635
  • 财政年份:
    2018
  • 资助金额:
    $ 45.13万
  • 项目类别:
Rescuing the ApoE4 genotype by activating sterol biosynthesis in the CNS
通过激活中枢神经系统中的甾醇生物合成来拯救 ApoE4 基因型
  • 批准号:
    9360281
  • 财政年份:
    2017
  • 资助金额:
    $ 45.13万
  • 项目类别:
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease
阿尔茨海默病中的胆固醇和鞘脂代谢
  • 批准号:
    9132655
  • 财政年份:
    2010
  • 资助金额:
    $ 45.13万
  • 项目类别:
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease
阿尔茨海默病中的胆固醇和鞘脂代谢
  • 批准号:
    8699618
  • 财政年份:
    2010
  • 资助金额:
    $ 45.13万
  • 项目类别:
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease
阿尔茨海默病中的胆固醇和鞘脂代谢
  • 批准号:
    9272296
  • 财政年份:
    2010
  • 资助金额:
    $ 45.13万
  • 项目类别:
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease
阿尔茨海默病中的胆固醇和鞘脂代谢
  • 批准号:
    8304236
  • 财政年份:
    2010
  • 资助金额:
    $ 45.13万
  • 项目类别:

相似海外基金

Functional Analysis of ACAT
ACAT的功能分析
  • 批准号:
    7610975
  • 财政年份:
    1998
  • 资助金额:
    $ 45.13万
  • 项目类别:
Functional Analysis of ACAT
ACAT的功能分析
  • 批准号:
    7424002
  • 财政年份:
    1998
  • 资助金额:
    $ 45.13万
  • 项目类别:
Functional Analysis of ACAT
ACAT的功能分析
  • 批准号:
    7261123
  • 财政年份:
    1998
  • 资助金额:
    $ 45.13万
  • 项目类别:
Functional Analysis of ACAT
ACAT的功能分析
  • 批准号:
    7774362
  • 财政年份:
    1998
  • 资助金额:
    $ 45.13万
  • 项目类别:
Cell Mutants Defective in Cholesterol Ester Formation
胆固醇酯形成有缺陷的细胞突变体
  • 批准号:
    8277279
  • 财政年份:
    1989
  • 资助金额:
    $ 45.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了